| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac316c4307d2a84add2bae0328f607bd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
| filingDate |
2017-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f062addac5e5ff9187140ffbf576a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e451281b6bdb9b599fe35f543f433f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a728251b8aef3d17b693ba93b5d6d891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9447d5641d08eb72d2e983a549a6f893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b64b323297d365e040a1074144d2af |
| publicationDate |
2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2702618-A1 |
| titleOfInvention |
Combination product comprising a modified mesenchymal stem cell and an antigenic substance. |
| abstract |
The present application provides a combination product for the treatment of cancer. The combination product comprises (i) a modified mesenchymal stem cell, and (ii) an antigenic substance. In addition, the present application also provides a method for the production of a modified mesenchymal stem cell comprising an intracellular parasite and a kit comprising (a) a mesenchymal stem cell, (b) an antigenic substance and (c) a receptor inhibitor. type Toll 4 and/or receiver type Toll 9. |
| priorityDate |
2017-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |